流式细胞术对预测乳腺癌患者复发和生存的影响。 - Suppr

Suppr

超能文献

Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.

作者信息

McGuire W l, Meyer J S, Barlogie B, Kute T E

出版信息

Breast Cancer Res Treat. 1985;5(2):117-28. doi: 10.1007/BF01805985.

DOI:10.1007/BF01805985

PMID:2410071

Abstract

摘要

相似文献

Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.流式细胞术对预测乳腺癌患者复发和生存的影响。

Breast Cancer Res Treat. 1985;5(2):117-28. doi: 10.1007/BF01805985.

Predicting recurrence and survival in breast cancer. A panel discussion.

Breast Cancer Res Treat. 1987;9(1):27-38. doi: 10.1007/BF01806691.

Prognostic factors in primary breast cancer.

Cancer Surv. 1986;5(3):527-36.

[Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].[除淋巴结和激素受体状态外，上皮生长因子受体（EGF-R）和DNA流式细胞术作为原发性乳腺癌的预后因素]

Geburtshilfe Frauenheilkd. 1989 Apr;49(4):375-8. doi: 10.1055/s-2008-1026603.

Prognosis in breast cancer.乳腺癌的预后

Recent Results Cancer Res. 1989;115:170-4. doi: 10.1007/978-3-642-83337-3_24.

Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.包括DNA直方图类型、受体含量以及分期在内的预后指标与人类乳腺癌患者的生存情况相关。

Cancer Res. 1984 Sep;44(9):4187-96.

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.1331例冷冻乳腺癌标本的DNA流式细胞术及预后因素

Cancer. 1988 Feb 1;61(3):420-7. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0.

Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.流式细胞术在预测乳腺癌患者复发和生存方面的新影响。

J Natl Cancer Inst. 1985 Sep;75(3):405-10.

Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.乳腺癌患者DNA流式细胞术及激素受体与腋窝淋巴结状态的相关性

Md Med J. 1994 Nov;43(11):963-5.

Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.乳腺癌的区域异质性：胸腺嘧啶核苷标记指数、类固醇激素受体、DNA倍体

Int J Cancer. 1991 Jan 21;47(2):213-20. doi: 10.1002/ijc.2910470209.

引用本文的文献

Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Breast Cancer Res Treat. 1985;6(2):113-21. doi: 10.1007/BF02235742.

Prognostic factors for recurrence and survival in human breast cancer.人类乳腺癌复发和生存的预后因素。

Breast Cancer Res Treat. 1987 Oct;10(1):5-9. doi: 10.1007/BF01806129.

Methylthioadenosine phosphorylase in human breast cancer.人乳腺癌中的甲硫腺苷磷酸化酶

Breast Cancer Res Treat. 1987;9(1):53-9. doi: 10.1007/BF01806694.

Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma.通过Ki-67免疫组织化学检测的增殖分数与可手术乳腺癌的组织学因素及激素受体的相关性

Breast Cancer Res Treat. 1989 Dec;14(3):329-36. doi: 10.1007/BF01806305.

Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.MCF-7人乳腺癌细胞和原发性乳腺癌组织中的特异性细胞质甲胎蛋白结合蛋白

Breast Cancer Res Treat. 1987 Dec;10(3):279-86. doi: 10.1007/BF01805765.

DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Jpn J Surg. 1990 Sep;20(5):491-7. doi: 10.1007/BF02471003.

Epidermal growth factor receptors and prognosis in primary breast cancer.原发性乳腺癌中的表皮生长因子受体与预后

Breast Cancer Res Treat. 1990 Dec;17(2):83-9. doi: 10.1007/BF01806288.

Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients.组织蛋白酶D总量在乳腺肿瘤中的预后价值。在选择化疗耐药患者中的可能作用。

Breast Cancer Res Treat. 1991 Oct;19(2):85-93. doi: 10.1007/BF01980938.

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67.使用单克隆抗体Ki-67对人类乳腺癌生长分数进行免疫组织化学评估。

Breast Cancer Res Treat. 1991 Aug;18(3):149-54. doi: 10.1007/BF01990030.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验